| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Adenosine receptor A2a |
|---|
| Ligand | BDBM303298 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | A2a Ki assay |
|---|
| Ki | 0.500±n/a nM |
|---|
| Citation |  Ali, A; Kuang, R; Lim, Y; Lo, MM; Ting, PC; Biju, P; de Lera Ruiz, M; Degrado, SJ; Tung, AL; Henderson, TJ; Hong, L; Kim, J; Kim, DW; Lee, J; Wu, J; Wu, H; Xiao, Y; Yu, T; Zhou, G; Zhu, X; McCormick, KD; Tagat, JR; Xiao, D; Khan, T; Cao, J; Berlin, M; Zhang, Y Aminoquinazoline compounds as A2A antagonist US Patent US10138212 Publication Date 11/27/2018 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Adenosine receptor A2a |
|---|
| Name: | Adenosine receptor A2a |
|---|
| Synonyms: | A2A adenosine receptor (hA2A) | AA2AR_HUMAN | ADENOSINE A2 | ADENOSINE A2a | ADORA2 | ADORA2A | Adenosine A2A receptor (A2AAR) |
|---|
| Type: | G Protein-Coupled Receptor (GPCR) |
|---|
| Mol. Mass.: | 44716.46 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P29274 |
|---|
| Residue: | 412 |
|---|
| Sequence: | MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAI
PFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTR
AKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYF
NFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVG
LFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFR
KIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNG
YALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
|
|
|
|---|
| BDBM303298 |
|---|
| n/a |
|---|
| Name | BDBM303298 |
|---|
| Synonyms: | 2-amino-8-fluoro-N-[(2- pyrazol-1- ylphenyl)methyl] quinazoline-4-carboxamide | US10138212, Example 62 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C19H15FN6O |
|---|
| Mol. Mass. | 362.3604 |
|---|
| SMILES | Nc1nc(C(=O)NCc2ccccc2-n2cccn2)c2cccc(F)c2n1 |$;;;;;;HN;;;;;;;;;;;;;;;;;;;;$| |
|---|
| Structure | 
|
|---|
Search and Browse
